secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sorrento Therapeutics, Inc. (—)
CIK:        0000850261
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001104659-23-115270
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Elizabeth Czerepak terminated; Sorrento cuts US workforce from 123 to 90
----------------------------------------------------------------------------

- On Nov 3, 2023, Sorrento terminated Elizabeth Czerepak as EVP and CFO, effective immediately.
- US headcount reduced from 123 to 90 employees, a 27% cut.
- No replacement CFO has been announced; CRO Mohsin Meghji signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/0001104659-23-115270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/tm2330125d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-115270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer